Skip to main content
Signal8

Hartley Dylan

SEC insider (Form 3/4/5 filer). CIK 0002037442. Chief Scientific Officer at OnKure Therapeutics, Inc. (OKUR). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOULDER, CO.

Companies Hartley Dylan has filed insider reports for

  • OnKure Therapeutics, Inc. (OKUR): Officer, Chief Scientific Officer
Hartley Dylan profile photo

Hartley Dylan

CIK: 0002037442

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OnKure Therapeutics, Inc. logo
OKUR

OnKure Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    50K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    137.6K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    137.6K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Apr 1, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    110K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Jan 27, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    45K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Oct 4, 2024
    Award

    Employee Stock Option (right to buy)

    Direct
    137.6K shares-

1-6 of 6